 Nicole Curci
Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Neoplasms | 12 | 2022 | 415 | 2.320 |
Why?
| | Carcinoma, Renal Cell | 7 | 2022 | 230 | 1.720 |
Why?
| | Prostatic Neoplasms | 8 | 2023 | 981 | 1.220 |
Why?
| | Magnetic Resonance Imaging | 11 | 2023 | 3916 | 0.830 |
Why?
| | Femoral Vein | 2 | 2012 | 38 | 0.710 |
Why?
| | Aneurysm | 2 | 2012 | 37 | 0.710 |
Why?
| | Catheter Ablation | 2 | 2022 | 355 | 0.630 |
Why?
| | Venous Thrombosis | 2 | 2012 | 196 | 0.610 |
Why?
| | Tomography, X-Ray Computed | 11 | 2024 | 2770 | 0.600 |
Why?
| | Embolization, Therapeutic | 2 | 2012 | 243 | 0.600 |
Why?
| | Prostate | 4 | 2018 | 159 | 0.590 |
Why?
| | Watchful Waiting | 1 | 2018 | 90 | 0.510 |
Why?
| | Kidney Diseases, Cystic | 3 | 2021 | 24 | 0.500 |
Why?
| | Radiology | 4 | 2021 | 174 | 0.490 |
Why?
| | Quality Assurance, Health Care | 1 | 2018 | 342 | 0.480 |
Why?
| | Pulmonary Artery | 2 | 2012 | 1129 | 0.470 |
Why?
| | Ovarian Neoplasms | 3 | 2024 | 596 | 0.360 |
Why?
| | Bezoars | 1 | 2011 | 5 | 0.350 |
Why?
| | Intussusception | 1 | 2011 | 26 | 0.340 |
Why?
| | Immunosuppressive Agents | 2 | 2012 | 838 | 0.320 |
Why?
| | Pneumonectomy | 1 | 2012 | 167 | 0.310 |
Why?
| | Intestine, Small | 1 | 2011 | 167 | 0.310 |
Why?
| | Radiology Information Systems | 2 | 2018 | 35 | 0.270 |
Why?
| | Ultrasonography | 3 | 2023 | 788 | 0.270 |
Why?
| | Biopsy | 4 | 2023 | 1082 | 0.260 |
Why?
| | Teaching | 2 | 2018 | 237 | 0.230 |
Why?
| | Retrospective Studies | 14 | 2024 | 17330 | 0.220 |
Why?
| | Microwaves | 2 | 2022 | 28 | 0.210 |
Why?
| | Neoplasm Grading | 3 | 2024 | 311 | 0.210 |
Why?
| | Ovarian Diseases | 1 | 2023 | 14 | 0.190 |
Why?
| | Magnetic Resonance Imaging, Interventional | 1 | 2023 | 30 | 0.190 |
Why?
| | Humans | 31 | 2024 | 145783 | 0.190 |
Why?
| | Kidney | 6 | 2021 | 1497 | 0.180 |
Why?
| | Cysts | 1 | 2023 | 112 | 0.180 |
Why?
| | Aged | 9 | 2024 | 26217 | 0.180 |
Why?
| | Prostatectomy | 2 | 2022 | 94 | 0.180 |
Why?
| | Angiography | 2 | 2012 | 208 | 0.170 |
Why?
| | Peritoneal Neoplasms | 1 | 2022 | 104 | 0.170 |
Why?
| | Syndrome | 2 | 2012 | 381 | 0.170 |
Why?
| | Neoadjuvant Therapy | 1 | 2024 | 467 | 0.160 |
Why?
| | Salpingo-oophorectomy | 1 | 2020 | 19 | 0.160 |
Why?
| | Diagnosis, Differential | 3 | 2021 | 1512 | 0.160 |
Why?
| | Contrast Media | 2 | 2021 | 497 | 0.160 |
Why?
| | Incidental Findings | 1 | 2020 | 81 | 0.150 |
Why?
| | Pelvic Neoplasms | 1 | 2020 | 24 | 0.150 |
Why?
| | Interdisciplinary Placement | 1 | 2019 | 2 | 0.150 |
Why?
| | Biliary Tract Neoplasms | 1 | 2020 | 31 | 0.150 |
Why?
| | Multidetector Computed Tomography | 1 | 2019 | 40 | 0.150 |
Why?
| | Robotic Surgical Procedures | 1 | 2022 | 185 | 0.150 |
Why?
| | Teacher Training | 1 | 2018 | 10 | 0.140 |
Why?
| | Radiography, Abdominal | 1 | 2018 | 44 | 0.140 |
Why?
| | Treatment Outcome | 5 | 2024 | 11794 | 0.140 |
Why?
| | Middle Aged | 11 | 2024 | 36309 | 0.140 |
Why?
| | Adrenal Gland Neoplasms | 1 | 2019 | 98 | 0.130 |
Why?
| | Education, Medical, Continuing | 1 | 2018 | 134 | 0.130 |
Why?
| | Glomerular Filtration Rate | 1 | 2021 | 765 | 0.120 |
Why?
| | Mentoring | 1 | 2019 | 166 | 0.120 |
Why?
| | Disease Progression | 1 | 2024 | 2865 | 0.120 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 442 | 0.120 |
Why?
| | Radiography | 1 | 2018 | 853 | 0.120 |
Why?
| | Risk Assessment | 2 | 2018 | 3752 | 0.110 |
Why?
| | Education, Medical | 1 | 2018 | 276 | 0.110 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2018 | 303 | 0.110 |
Why?
| | Male | 13 | 2023 | 73011 | 0.100 |
Why?
| | Adipose Tissue | 1 | 2019 | 645 | 0.100 |
Why?
| | Machine Learning | 1 | 2019 | 587 | 0.100 |
Why?
| | Reproducibility of Results | 2 | 2018 | 3418 | 0.100 |
Why?
| | Follow-Up Studies | 2 | 2012 | 5428 | 0.090 |
Why?
| | Predictive Value of Tests | 1 | 2018 | 2123 | 0.090 |
Why?
| | Transcriptome | 1 | 2018 | 1042 | 0.090 |
Why?
| | Prunus | 1 | 2011 | 2 | 0.090 |
Why?
| | Abdomen, Acute | 1 | 2011 | 21 | 0.090 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 2000 | 0.090 |
Why?
| | Vena Cava Filters | 1 | 2012 | 64 | 0.080 |
Why?
| | Rare Diseases | 1 | 2012 | 116 | 0.080 |
Why?
| | Female | 11 | 2024 | 79045 | 0.080 |
Why?
| | Prednisone | 1 | 2012 | 226 | 0.080 |
Why?
| | Internship and Residency | 2 | 2018 | 1269 | 0.080 |
Why?
| | Longitudinal Studies | 1 | 2018 | 2968 | 0.080 |
Why?
| | Prospective Studies | 2 | 2023 | 8078 | 0.080 |
Why?
| | Combined Modality Therapy | 1 | 2012 | 1271 | 0.070 |
Why?
| | Vascular Surgical Procedures | 1 | 2012 | 343 | 0.070 |
Why?
| | Glucocorticoids | 1 | 2012 | 532 | 0.070 |
Why?
| | Laparoscopy | 1 | 2011 | 481 | 0.060 |
Why?
| | Adult | 5 | 2020 | 40881 | 0.060 |
Why?
| | CA-125 Antigen | 1 | 2024 | 13 | 0.050 |
Why?
| | Societies, Medical | 2 | 2019 | 900 | 0.050 |
Why?
| | Severity of Illness Index | 1 | 2012 | 2933 | 0.050 |
Why?
| | Cytoreduction Surgical Procedures | 1 | 2024 | 69 | 0.050 |
Why?
| | Torsion Abnormality | 1 | 2023 | 20 | 0.050 |
Why?
| | Image-Guided Biopsy | 1 | 2023 | 41 | 0.050 |
Why?
| | Urologists | 1 | 2023 | 17 | 0.050 |
Why?
| | Cystadenocarcinoma, Serous | 1 | 2024 | 89 | 0.050 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2024 | 427 | 0.050 |
Why?
| | Gallium Isotopes | 1 | 2022 | 1 | 0.050 |
Why?
| | Gallium Radioisotopes | 1 | 2022 | 16 | 0.050 |
Why?
| | Neoplasm, Residual | 1 | 2022 | 143 | 0.040 |
Why?
| | Radiologists | 1 | 2021 | 61 | 0.040 |
Why?
| | Algorithms | 2 | 2019 | 1851 | 0.040 |
Why?
| | Peer Review | 1 | 2019 | 47 | 0.040 |
Why?
| | Portal Vein | 1 | 2020 | 117 | 0.040 |
Why?
| | Angiomyolipoma | 1 | 2019 | 21 | 0.040 |
Why?
| | Pelvis | 1 | 2020 | 125 | 0.040 |
Why?
| | Cohort Studies | 2 | 2020 | 6033 | 0.030 |
Why?
| | Organizational Objectives | 1 | 2018 | 67 | 0.030 |
Why?
| | Digital Rectal Examination | 1 | 2018 | 10 | 0.030 |
Why?
| | Faculty | 1 | 2019 | 148 | 0.030 |
Why?
| | Artifacts | 1 | 2019 | 143 | 0.030 |
Why?
| | Molecular Diagnostic Techniques | 1 | 2018 | 104 | 0.030 |
Why?
| | Carbon | 1 | 2019 | 176 | 0.030 |
Why?
| | Prostate-Specific Antigen | 1 | 2018 | 161 | 0.030 |
Why?
| | Education, Distance | 1 | 2018 | 59 | 0.030 |
Why?
| | Problem-Based Learning | 1 | 2018 | 97 | 0.030 |
Why?
| | Peer Group | 1 | 2019 | 256 | 0.030 |
Why?
| | Adipocytes | 1 | 2019 | 223 | 0.030 |
Why?
| | Terminology as Topic | 1 | 2019 | 259 | 0.030 |
Why?
| | Delphi Technique | 1 | 2018 | 333 | 0.030 |
Why?
| | Needs Assessment | 1 | 2019 | 403 | 0.030 |
Why?
| | Consensus | 1 | 2018 | 479 | 0.030 |
Why?
| | Evidence-Based Practice | 1 | 2018 | 231 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2023 | 3634 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2018 | 364 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2021 | 869 | 0.030 |
Why?
| | Research Design | 1 | 2021 | 1139 | 0.030 |
Why?
| | Learning | 1 | 2018 | 444 | 0.030 |
Why?
| | Gene Expression | 1 | 2018 | 1478 | 0.020 |
Why?
| | Genomics | 1 | 2018 | 830 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2020 | 2399 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2022 | 5925 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 4330 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2021 | 8347 | 0.020 |
Why?
| | Child, Preschool | 1 | 2023 | 11868 | 0.020 |
Why?
| | Child | 1 | 2023 | 22740 | 0.010 |
Why?
|
|
Curci's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|